News Summary: Anticlot drug Eliquis OK'd in Japan

Published on NewsOK Modified: December 26, 2012 at 1:25 pm •  Published: December 26, 2012
Advertisement
;

THIRD APPROVAL: Regulators in Japan have approved anticlotting drug called Eliquis, a potential blockbuster from Bristol-Myers Squibb and Pfizer. It's already on sale in Canada and the European Union.

THIRD TRY: The U.S. Food and Drug Administration has twice postponed a decision on Eliquis, first saying it needed more time and then requiring additional data. That was submitted in September, and the FDA now is set to rule by March 17.

THIRD DRUG: Two similar drugs already on sale have a big head start — Pradaxa, from Germany's Boehringer Ingelheim, and Xarelto, from partners Johnson & Johnson and Bayer Healthcare.



Trending Now


AROUND THE WEB

  1. 1
    Report: Florida State WR Jesus Wilson arrested, suspended for stealing motor scooter
  2. 2
    Listen to Britney Spears sing without Auto-Tune
  3. 3
    'Walking Dead' shut out of major Emmy categories
  4. 4
    Little Boy's Heartwarming Back-To-School Video Goes Viral
  5. 5
    Ellen DeGeneres Ready for 'Next Phase' of Her Career
+ show more